|
The Fight Against Aging
Quincy Bioscience is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to treat the diseases of aging. The company's products focus on alleviating the consequences of impaired calcium homeostasis - the imbalance of calcium ions commonly thought to be related to neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Quincy Bioscience is set apart by its cutting-edge applications of the calcium-binding protein aequorin, which is breaking new ground in the fight against neuronal degeneration.
|
|
|
Quincy Bioscience is dedicated to fighting aging on several fronts. In addition to our pharmaceutical aspirations we have developed a novel dietary supplement using our patent-pending technology. Our first supplement, Prevagen™, is now available nationwide in health food stores and Rite-Aid chain drug stores. The only supplement from a jellyfish, Prevagen keeps brain cells alive longer. * Our research shows a 28-55% reduction in cellular death when treated with the jellyfish compound within Prevagen. Prevagen was developed by Quincy Bioscience and is the first supplement to address aging through the restoration of calcium-binding proteins. For more information please visit our website at
www.prevagen.com.
|
Recent News about Quincy Bioscience
August 26, 2007: Talk 650 KSTE - Mark Underwood appears on The Wide World of Health
May 24, 2007: NBC - Jellyfish helping prevent injury from strokes
May 16, 2007: Milwaukee Journal Sentinel - Madison company to use animal's proteins to fight aging
May 1, 2007: Channel 3 WISC TV Madison - Jellyfish Fight Aging
March 23, 2007: Quincy Bioscience presents at BIO 2007 Convention in Boston, MS
|